Provider: BehaviorLive — via AVBCC
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →This session focuses on the expanding infusion landscape beyond cancer care needs, as products acquire new treatment indications and drug pipeline continues to expand. Oncology care, with decades of experience with buy-and-bill, is uniquely positioned to identify avenues to serve an increasing patient care need as therapies reach new patient populations. This session will provide perspectives from different organization's approaches to expanding infusion services to meet this expanding patient care need while diversifying services and revenue streams.
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
Jorge J. García obtained his Doctor of Pharmacy (PharmD) and Master of Business Administration (MBA) from NovaSoutheastern University (NSU) in 2010. He then transitioned to the University of Pittsburgh Medical Center (UPMC)to pursue an American Society of Health-System Pharmacy (ASHP)-accredited PGY-1 & PGY-2 Health-SystemPharmacy Administration Residency and a Master of Science (MS) in Pharmacy Administration. He also completed anMaster of Healthcare Administration (MHA) from Florida Atlantic University (FAU). Dr. García has previously served inthe roles of inpatient pharmacy operations coordinator as well as director of pharmacy for system-wide oncologypharmacy services.Dr. García currently serves as an Assistant Vice President (AVP) at Baptist Health South Florida (BHSF) withresponsibility for system-wide acute and ambulatory oncology pharmacy services, system-wide ambulatory non-oncology infusion pharmacy services, and system-wide investigational drug pharmacy services. He has pioneeredpharmacy charge integrity and revenue management initiatives in the health-system setting and is a thought leader andnational speaker in this area, as well as in the areas of alternative payment models, biosimilars, 505(b)2 drugs, drugbagging practices, and value-based care. Dr. García also directs multiple national conferences tasked with thedissemination of emerging clinical evidence while also highlighting opportunities to leverage patient care andorganizational value. Dr. García leads advocacy efforts at the national level to promote access to medicines, as well asaccess to high-quality standards in the oncology, infusion, and investigational drug setting. Dr. García has served as aboard member at Florida Society of Clinical Oncology (FLASCO) since 2015 and is also a previous recipient of theFLASCO Above and Beyond Award, which honored his exceptional dedication and innovative contributions to thesociety. He also currently serves on multiple committees at ASHP. In 2020, Dr. García was also appointed to theBoard of Trustees at Association of Cancer Care Centers (ACCC) and currently serves in multiple committees andserves as the organization’s executive secretary. In addition, Dr. García is a founding member of the Advanced Topicsfor Oncology Pharmacy Professionals (ATOPP) national conference, and currently serves as the organization’s chair.He also currently serves as faculty for the ASHP Foundation Pharmacy Leadership Academy (PLA). Dr. García is afellow of ACCC and a fellow of the American College of Healthcare Executives (ACHE).
Dig into the research behind this topic — plain-English summaries written for BCBAs.
258 research articles with practitioner takeaways
244 research articles with practitioner takeaways
225 research articles with practitioner takeaways
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.